12:10 – 12:30 pm Friday, October 29

Paper Presentation: Supportive Care/Quality Improvement — Beyond Words: Expressing Hope Through Creative Art Among Adolescents Who Have Advanced Cancer (216-3)

Purpose/Objectives: This study aimed to (1) conceptualize the essence of hope among adolescents with advanced cancer based on their lived experiences and (2) illustrate how hope evolves through participants’ verbal and artistic depictions of their lived experiences with hope. Four of these drawings and verbatim descriptions are presented as a case series.

Read more...
11:30 am – 12:30 pm Saturday, October 30

Stopping the Flow: Management of Heavy Menstrual Bleeding and Menstrual Concerns in Adolescent Females with Bleeding and Clotting Disorders (226)

Heavy menstrual bleeding (HMB) and dysmenorrhea are common complaints among adolescent females (O’Brien, 2018). For females with underlying bleeding and clotting disorders, managing their menstrual bleeding can provide challenges unique to their stages of life.

Read more...
Speaker:
Elizabeth Vessey, NP
CNE Hours
1
11:30 am – 12:30 pm Friday, October 29

Joint Topic: Anticoagulation Therapy Anticoagulation Alphabet Soup: VKAs, LMWHs, and DOACs (214-1)

Treatment of thrombosis in pediatric patients presents many challenges. Thrombosis in pediatric patients has a wide range of etiologies, and researchers lack consensus about duration of therapy based on the thrombosis location and the presence of risk factors. Most patients under 18 years of age are treated with either parenteral low-molecular-weight heparins (LMWH) or vitamin K antagonists (VKAs).

Read more...
Speaker:
Ashleigh Brown, BSN RN CPN CPHON®
CNE Hours
1
RX Hours
0.25
2:15 – 3:15 pm Saturday, October 30

Treating Smarter, Not Harder: Abandoning Intensification and Replacing with Immunotherapy for Patients with Down Syndrome and B-ALL (C234)

coglogoChildren with Down syndrome (DS) have a striking predisposition for developing acute leukemia, with a 40-fold increased risk of developing acute lymphoblastic leukemia (ALL) compared to non-DS patients (Wadhwa et al, 2017). Approximately 3% of children with ALL have DS, and these children have inferior outcomes and higher rates of treatment-related mortality (TRM) and are at greater risk of relapse (Buitenkamp et al., 2014).

Read more...
11:30 am – 12:30 pm Saturday, October 30

Clinical Trials in the Children’s Oncology Group: A Case Study Approach (C229)

coglogoClinical trials are essential in the treatment of pediatric and young adult patients with cancer and have resulted in dramatic improvements in cure rates over the years. Because of clinical trials, we are now better able to understand the biology of different types of cancers affecting children and young adults and determine the best treatment options.

Read more...
3:30 – 4:30 pm Friday, October 29

Incorporating Children’s Oncology Group Health Links into Clinical Practice (C223)

coglogoThe care of children with cancer spans diagnosis and treatment, with the goal being survivorship. Approximately 80% of children diagnosed with cancer will survive, and many childhood cancer survivors may experience both physical and psychological late effects secondary to their cancer or its treatment.

Read more...
3:30 – 4:30 pm Friday, October 29

Hot Topics in Pediatric Oncology: Updates from the Children’s Oncology Group (C217)

coglogoImprovements in patient care occur when new research findings are moved into practice. The average length of time for this translation, however, is 17 years. Within the past 3 years, the Children’s Oncology Group (COG) has produced 248 publications (about 83 per year).

Read more...
5:00 – 6:00 pm Thursday, October 28

Lighting the Way in COG with MATCH: Targeted Therapies in Pediatric CNS Tumors (C211)

coglogoPediatric MATCH (Molecular Analysis for Therapy Choice) is a joint effort between the National Cancer Institute (NCI) and Children’s Oncology Group (COG) matching targeted therapies to specific tumor genomic sequencing in patients with relapsed or refractory solid tumors, non-Hodgkin lymphomas, brain tumors, and histiocytic disorders.

Read more...
11:30 am – 12:30 pm Saturday, October 30

Paper Presentation: Program Development — Building a Sustainable and Structured Continuing Education Program for Pediatric Oncology Nurses in Vietnam (228-3)

There is a lack of continuing education opportunities for oncology nurses at the 13 pediatric cancer treatment centers in Vietnam. This presentation will discuss how nurses from the United States, Singapore, and Vietnam collaborated to develop an in-country, web-based educational program utilizing a variety of virtual teaching strategies.

Read more...
Subscribe to this RSS feed